The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
C-Reactive Protein, Interleukin-6, and Soluble Adhesion Molecules as Predictors of Progressive Peripheral Atherosclerosis in the General Population: Edinburgh Artery Study
Abstract
Background— The relationship between levels of circulating inflammatory markers and risk of progressive atherosclerosis is relatively undetermined. We therefore studied inflammatory markers as predictors of peripheral atherosclerotic progression, measured by the ankle-brachial index (ABI) at 3 consecutive time points over 12 years. Methods and Results— The Edinburgh Artery Study is a population cohort study of 1592 men and women aged 55 to 74 years. C-reactive protein (CRP), interleukin-6 (IL-6), intercellular adhesion molecule-1 (ICAM-1), vascular adhesion molecule-1 (VCAM-1), and E-selectin were measured at baseline. Valid ABI measurements were obtained on 1582, 1081, and 813 participants at baseline and 5-year and 12-year follow-up examinations, respectively. At baseline, a significant trend was found between higher plasma levels of CRP ( P ≤0.05) and increasing severity of peripheral arterial disease (PAD), after adjustment for baseline cardiovascular risk factors. IL-6 at baseline ( P ≤0.001) was associated with progressive atherosclerosis at 5 years (ABI change from baseline), and CRP ( P ≤0.01), IL-6 ( P ≤0.001), and ICAM-1 ( P ≤0.01) were associated with changes at 12 years, independently of baseline ABI, cardiovascular risk factors, and baseline cardiovascular disease. Only IL-6 independently predicted ABI change at 5 years ( P ≤0.01) and 12 years ( P ≤0.05) in analyses of all inflammatory markers simultaneously and adjusted for baseline ABI, cardiovascular risk factors, and cardiovascular disease at baseline. Conclusions— These findings suggest that CRP, IL-6, and ICAM-1 are molecular markers associated with atherosclerosis and its progression. IL-6 showed more consistent results and stronger independent predictive value than other inflammatory markers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Self-citationRidker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
Koenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,964
The diagnosis of ischaemic heart pain and intermittent claudication in field surveys.
Rose, G. A. (1962) · Europe PMC (PubMed Central) · Cited by 1,320
Ridker, P. M., Stampfer, M. J., & Rifai, N. (2001) · JAMA · doi:10.1001/jama.285.19.2481 · Cited by 1,296
FOWKES, F. G. R., HOUSLEY, E., CAWOOD, E. H. H., MACINTYRE, C. C. A., RUCKLEY, C. V., & PRESCOTT, R. J. (1991) · International Journal of Epidemiology · doi:10.1093/ije/20.2.384 · Cited by 1,181
Self-citationRelation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control Study
for the MRFIT Research Group, Kuller, L. H., Tracy, R. P., Shaten, J., & Meilahn, E. N. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008963 · Cited by 1,097
Cited by
Kohut, M. L., McCann, D. A., Russell, D. W., Konopka, D. N., Cunnick, J. E., Franke, W. D., Castillo, M. C., Reighard, A. E., & Vanderah, E. (2006) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.12.002 · Cited by 436
“Atherosclerosis and coronary artery disease are associated with greater levels of C-reactive protein (CRP), interleukin (IL)-6, and tumor necrosis factor (TNF)(Larsson et al., 2005; Ridker et al., 2003; Schwartz et al., 2003; Tzoulaki et al., 2005).”
BackgroundOlive oil and the cardiovascular system
COVAS, M. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.01.010 · Cited by 401
Effects of particulate matter (PM10, PM2.5 and PM1) on the cardiovascular system
Polichetti, G., Cocco, S., Spinali, A., Trimarco, V., & Nunziata, A. (2009) · Toxicology · doi:10.1016/j.tox.2009.04.035 · Cited by 362
Paré, G., Chasman, D. I., Kellogg, M., Zee, R. Y. L., Rifai, N., Badola, S., Miletich, J. P., & Ridker, P. M. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000118 · Cited by 341
“Underlining the complex nature of the biological processes involved, the A1 group (rs507666) is associated with lower levels of sICAM-1, a (positive) predictor of vascular diseases in epidemiological studies [5,6,43–46].”
BackgroundInflammation in Peripheral Artery Disease
Brevetti, G., Giugliano, G., Brevetti, L., & Hiatt, W. R. (2010) · Circulation · doi:10.1161/circulationaha.109.918417 · Cited by 313
Wang, Y., Zhao, X., Jin, H., Wei, H., Li, W., Bu, D., Tang, X., Ren, Y., Tang, C., & Du, J. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.179333 · Cited by 307
Exercise Rehabilitation in Peripheral Artery Disease: Functional Impact and Mechanisms of Benefits
Hamburg, N. M., & Balady, G. J. (2011) · Circulation · doi:10.1161/circulationaha.109.881888 · Cited by 294
Risk Factors for Progression of Peripheral Arterial Disease in Large and Small Vessels
Aboyans, V., Criqui, M. H., Denenberg, J. O., Knoke, J. D., Ridker, P. M., & Fronek, A. (2006) · Circulation · doi:10.1161/circulationaha.105.608679 · Cited by 290
Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels
Barbalic, M., Dupuis, J., Dehghan, A., Bis, J. C., Hoogeveen, R. C., Schnabel, R. B., Nambi, V., Bretler, M., Smith, N. L., Peters, A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq061 · Cited by 279
Csiszar, A., Smith, K., Labinskyy, N., Orosz, Z., Rivera, A., & Ungvari, Z. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00340.2006 · Cited by 274
Rajesh, M., Mukhopadhyay, P., Bátkai, S., Haskó, G., Liaudet, L., Huffman, J. W., Csiszar, A., Ungvari, Z., Mackie, K., Chatterjee, S., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00688.2007 · Cited by 260
DONGES, C. E., DUFFIELD, R., & DRINKWATER, E. J. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181b117ca · Cited by 258
Grenon, S. M., Vittinghoff, E., Owens, C. D., Conte, M. S., Whooley, M., & Cohen, B. E. (2013) · Vascular Medicine · doi:10.1177/1358863x13493825 · Cited by 169
Nestel, P. J., Mellett, N., Pally, S., Wong, G., Barlow, C. K., Croft, K., Mori, T. A., & Meikle, P. J. (2013) · British Journal of Nutrition · doi:10.1017/s0007114513001621 · Cited by 81
Cho, K.-H. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.7.393 · Cited by 74
Brevetti, G., Schiano, V., Sirico, G., Giugliano, G., Laurenzano, E., & Chiariello, M. (2006) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.02.048 · Cited by 55
Kremers, B. M. M., Posma, J. N., Heitmeier, S., Glunz, J., ten Cate, H., Pallares Robles, A., Daemen, J. H. C., ten Cate-Hoek, A. J., Mees, B. M. E., & Spronk, H. M. H. (2022) · Scientific Reports · doi:10.1038/s41598-022-23260-3 · Cited by 17
Metadata
- Authors
- Tzoulaki, I., Murray, G. D., Lee, A. J., Rumley, A., Lowe, G. D. O., & Fowkes, F. G. R.
- Venue
- Circulation
- Published
- 2005-08-16
- Volume
- 112
- Issue
- 7
- Pages
- 976-983
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2068218731
- Cited by
- 428
- References
- 48
- FWCI
- 32.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.